gms | German Medical Science

65. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

11. - 14. Mai 2014, Dresden

Impact of the extend of resection for low-grade glioma on recurrence and malignant progression – retrospective analysis using the UCSF scoring system

Meeting Abstract

  • Mirjam Renovanz - Klinik für Neurochirurgie, Universitätsmedizin Mainz
  • Naureen Keric - Klinik für Neurochirurgie, Universitätsmedizin Mainz
  • Oliver Korczynski - Institut für Neuroradiologie, Universitätsmedizin Mainz
  • Thomas Just - Klinik für Neurochirurgie, Bundeswehrkrankenhaus Koblenz
  • Christoph Richter - Klinik für Neurochirurgie, Universitätsmedizin Mainz
  • Alf Giese - Klinik für Neurochirurgie, Universitätsmedizin Mainz

Deutsche Gesellschaft für Neurochirurgie. 65. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC). Dresden, 11.-14.05.2014. Düsseldorf: German Medical Science GMS Publishing House; 2014. DocP 074

doi: 10.3205/14dgnc470, urn:nbn:de:0183-14dgnc4705

Veröffentlicht: 13. Mai 2014

© 2014 Renovanz et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.de). Er darf vervielfältigt, verbreitet und öffentlich zugänglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.


Gliederung

Text

Objective: In recent years it became evident that patients with low-grade glioma (LGG) benefit from gross total resection (GTR) with respect to PFS and OS compared to patients receiving subtotal resection (STR) or biopsy. Furthermore GTR seems to improve seizure control. The aim of this study was to evaluate patients' outcome concerning extent of resection (EOR) using the UCSF scoring system [1].

Method: 76 Patients with initial diagnosis of LGG treated 1997–2013 were retrospectively evaluated. Inclusion criteria were: diagnosis of LGG and availability of pre-OP MRI. We evaluated PFS and OS, clinical course and treatment strategies. Furthermore the UCSF1 scoring criteria were evaluated (eloquent location, KPS, age, maximum diameter of the tumor).

Results: 44 patients with a mean follow-up of 80.3 months (range 5–288) with initial LGG were identified in our database fulfilling the inclusion criteria. 26 were male, 18 were female, mean age at diagnosis was 40 years (SD: ± 14 years, range 14–65). Concerning UCSF criteria, mean KPS was 93 (range 70–100), 26 tumors were located in eloquent areas and 18 patients had a tumor diameter >4 cm. GTR could be achieved in 18 cases, STR or biopsy of the tumor was performed in 26 cases. In the group of STR significantly more patients (n=18) experienced malignant progression whereas in the group with GTR 6 patients had malignant progression (Fisher’s exact, p=0.04).

Conclusions: In the era of molecular genetic prognostic factors GTR remains an important predictive factor for malignant progression which can be identified even in in relatively small patient populations, highlighting the importance of surgical removal. The UCSF scoring system for LGG is easily applied preoperatively helping to define the goals of the treatment for individual patients.


References

1.
Chang EF, Clark A, Jensen RL, Bernstein M, Guha A, Carrabba G, Mukhopadhyay D, Kim W, Liau LM, Chang SM, Smith JS, Berger MS, McDermott MW. Multiinstitutional validation of the University of California at San Francisco Low-Grade Glioma Prognostic Scoring System. Clinical article. J Neurosurg. 2009 Aug;111(2):203-10. DOI: 10.3171/2009.2.JNS081101 Externer Link